University of Luebeck
102
13
20
56
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.9%
5 terminated/withdrawn out of 102 trials
91.8%
+5.3% vs industry average
11%
11 trials in Phase 3/4
2%
1 of 56 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (102)
Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network
Role: lead
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
Role: collaborator
Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
Role: lead
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
Role: collaborator
Intermittent Fasting to Improve Insulin Secretion
Role: collaborator
Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators
Role: collaborator
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
Role: lead
Comprehensive Biomarker ProfiliNg in PatieNts With VEntriCular TachyCardia, PremAtuRe VEntricular Contractions, and AVNRT
Role: lead
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
Role: lead
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
Role: collaborator
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Role: collaborator
Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction
Role: lead
Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation
Role: lead
Real-world Evidence on Follitropin Delta Individual Dosing
Role: lead
Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
Role: lead
Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients with Myocardial Infarction and No-reflow
Role: lead
PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study
Role: lead
Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation
Role: lead
Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias
Role: lead
Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation
Role: lead